文献速递免疫规划传染病防控与疫情报告

巴西10价肺炎球菌结合疫苗对儿童鼻咽部肺炎链球菌携带的长期影响

Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil.
PubMed 文献 · Vaccine · 2019-07-24

巴西2010年将PCV10纳入国家免疫规划,2017年在圣保罗市对531名12至<24月龄儿童开展携带率调查,并与2010年基线及2013年调查比较。PCV10引入7年后,疫苗型携带较基线下降95.5%至0.9%,非疫苗型携带增加185%至55.9%,出现血清型替换及19A克隆CC320 emergence。

要点

  • PCV10引入7年后,疫苗型肺炎链球菌携带降至0.9%,较基线下降95.5%。
  • 非疫苗型携带升至55.9%,以6C、15B、19A、15A、16F为主。
  • 19A克隆CC320出现,与青霉素和头孢噻肟高水平耐药相关。

核心结论

  • PCV10纳入国家免疫规划7年后,幼儿疫苗型肺炎链球菌携带显著下降至残余水平,但非疫苗型血清型替换明显,包括当前结合疫苗未覆盖的血清型及19A。

研究设计与样本

  • 2017年在圣保罗市公共卫生初级卫生单位招募531名12至<24月龄儿童开展鼻咽部携带率横断面调查,采用与既往调查相同方法(qPCR仅2017年开展),并与2010年基线及2013年调查比较。

主要发现

  • 2017年培养法肺炎链球菌携带率为59.7%,qPCR法为61.2%,两者无统计学差异。
  • 携带率从基线40.3%升至2017年59.7%(p < 0.001)。
  • 疫苗型分离株较基线在2013年和2017年分别显著下降90.9%(19.8-1.8%)和95.5%(19.8-0.9%)。
  • 非疫苗型分离株在2013年和2017年分别显著增加128%(19.6-44.8%)和185%(19.6-55.9%)。
  • 2017年主要非疫苗血清型为6C(27%)、15B(9.8%)、19A(9.2%)、15A(6.0%)和16F(5.7%);6A从4.2%降至0.6%(p < 0.001),19A从1.8%升至6.0%(p = 0.001),未检出3型。

临床怎么用

  • 监测PCV10长期使用后非疫苗型血清型替换及19A克隆CC320的出现,为巴西疫苗政策调整提供依据。

局限性

  • qPCR仅在2017年调查中开展,与既往调查方法不完全一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Brazil introduced the 10-valent pneumococcal vaccine (PCV10) to the routine national immunization program (NIP) in March 2010. In 2017, we investigated the effects of PCV10 on nasopharyngeal carriage of vaccine-types (VT) and non-vaccine-types (NVT) of Streptococcus pneumoniae (Spn) among children living in São Paulo city. We also compared the prevalence of VT and NVT with previous carriage surveys performed in 2010 (baseline) and 2013. METHOD: The carriage survey was conducted among 531 children, aged 12 months to <24 months, recruited from public Primary Health Units during the immunization campaign, using previous surveys methodology, except for qPCR, which was performed in the 2017 survey only. RESULTS: No statistical difference was found in the prevalence of Spn either by culture (59.7%) or by qPCR (61.2%). Spn carriage increased from 40.3% (baseline) to 59.7% (2017 survey) (p < 0.001). Colonization by VT isolates significantly decreased by 90.9% (19.8-1.8%) and 95.5% (19.8-0.9%) in the 2013 and 2017 surveys, respectively, compared to that at baseline. NVT isolates increased significantly by 128% (19.6-44.8%) and 185% (19.6-55.9%) in the respective post-PCV10 surveys, most led to high prevalence of serotypes 6C (27%), 15B (9.8%), 19A (9.2%), 15A (6.0%), and 16F (5.7%). In 2017, reduction in serotype 6A (4.2-0.6%, p < 0.001) and increase in serotype 19A (1.8-6.0%, p = 0.001) were found; serotype 3 isolate was not detected in the present survey. We identified the emergence of 19A isolates CC320, associated with high penicillin (MIC ≥ 2.0 mg/L) and cefotaxime (MIC ≥ 1.0 mg/L) values. CONCLUSION: After 7 years of PCV10 introduction in the NIP, colonization by VT among toddlers decreased substantially to a residual level, along with substantial serotype replacement by novel serotypes not present in any current conjugated pneumococcal vaccine and serotype 19A. The present findings can assist policy decisions in Brazil.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Brandileone MC, Zanella RC, Almeida SCG, et al. Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil. Vaccine. 2019. PMID: 31351796. doi:10.1016/j.vaccine.2019.07.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。